Results 261 to 270 of about 7,054,284 (355)

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

open access: yesMolecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli   +7 more
wiley   +1 more source

Center for Species Survival Nigeria launches programme of work

open access: yesOryx
Bello A. Danmallam   +5 more
doaj   +1 more source

Comparison of the Kaplan-Meier survival curves according to occurrence of AE in patients with IPF.

open access: green
Eun Jun Choe (21453761)   +5 more
openalex   +1 more source

Targeting p38α in cancer: challenges, opportunities, and emerging strategies

open access: yesMolecular Oncology, EarlyView.
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley   +1 more source

Association of Sleep Disturbance With Survival After Colorectal Cancer Diagnosis: Results From the ColoCare Study. [PDF]

open access: yesCancer Med
Peoples AR   +18 more
europepmc   +1 more source

Kaplan-Meier survival curve in patients using HFNC according to IMV.

open access: green
Edwin Aguirre-Milachay (15453672)   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy